U.S. Physical Therapy, Inc. (NYSE:USPH) Director Edward L. Kuntz Sells 2,500 Shares

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Edward L. Kuntz sold 2,500 shares of the business’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $107.57, for a total transaction of $268,925.00. Following the completion of the transaction, the director now owns 3,280 shares of the company’s stock, valued at $352,829.60. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

U.S. Physical Therapy Trading Down 0.3 %

Shares of U.S. Physical Therapy stock traded down $0.33 during mid-day trading on Friday, hitting $105.92. The stock had a trading volume of 8,931 shares, compared to its average volume of 68,282. The firm has a 50-day moving average of $105.46 and a two-hundred day moving average of $97.14. The firm has a market cap of $1.60 billion, a P/E ratio of 86.38, a price-to-earnings-growth ratio of 4.11 and a beta of 1.39. The company has a quick ratio of 2.16, a current ratio of 2.16 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy, Inc. has a 12-month low of $78.08 and a 12-month high of $124.11.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Tuesday, May 7th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.58 by ($0.07). U.S. Physical Therapy had a return on equity of 8.03% and a net margin of 4.72%. The business had revenue of $155.70 million during the quarter, compared to analysts’ expectations of $153.30 million. During the same quarter in the previous year, the company posted $0.59 earnings per share. The company’s revenue was up 4.8% on a year-over-year basis. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.9 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Thursday, May 23rd will be issued a $0.44 dividend. The ex-dividend date of this dividend is Wednesday, May 22nd. This represents a $1.76 annualized dividend and a yield of 1.66%. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 143.09%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of USPH. Park Avenue Securities LLC purchased a new stake in shares of U.S. Physical Therapy in the 3rd quarter valued at $232,000. NBC Securities Inc. acquired a new stake in shares of U.S. Physical Therapy during the third quarter worth about $989,000. Victory Capital Management Inc. boosted its stake in shares of U.S. Physical Therapy by 9.4% in the third quarter. Victory Capital Management Inc. now owns 43,461 shares of the company’s stock valued at $3,987,000 after purchasing an additional 3,722 shares during the period. Illinois Municipal Retirement Fund acquired a new position in shares of U.S. Physical Therapy in the third quarter valued at approximately $812,000. Finally, New York State Common Retirement Fund grew its holdings in shares of U.S. Physical Therapy by 7.3% in the third quarter. New York State Common Retirement Fund now owns 16,901 shares of the company’s stock valued at $1,550,000 after purchasing an additional 1,152 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. StockNews.com raised shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Monday, March 18th. Barrington Research reaffirmed an “outperform” rating and set a $122.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, May 9th. Finally, JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an “overweight” rating in a research note on Wednesday, March 13th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $125.67.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.